Fresenius Kabi’s Biosimilar for Actemra Gets FDA Approval

Another biosimilar approval from the FDA was handed down Thursday, as the regulator approved Fresenius Kabi’s Tyenne biosimilar for Genentech’s Acterma (tocilizumab).